Actinium Pharmaceuticals Inc. buy melinda
Start price
28.07.17
/
50%
€15.00
Target price
23.10.17
€36.00
Performance (%)
20.80%
End price
23.10.17
€18.12
Summary
This prediction ended on 23.10.17 with a price of €18.12. The prediction had a final performance of 20.80%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Actinium Pharmaceuticals Inc. | -2.212% | -2.212% | -37.500% | -87.273% |
| iShares Core DAX® | -1.779% | 2.475% | 1.471% | 58.088% |
| iShares Nasdaq 100 | 1.522% | 3.290% | 33.721% | 91.613% |
| iShares Nikkei 225® | 1.083% | 7.039% | 59.258% | 78.826% |
| iShares S&P 500 | 0.929% | 3.254% | 24.730% | 70.002% |
Comments by melinda for this prediction
In the thread Actinium Pharmaceuticals Inc. diskutieren
PHARMA
Actinium Pharmaceuticals, Inc. (NYSE Amex: ATNM) ihre Absicht angekündigt , die Aktien und Optionsscheine in einem öffentlichen Angebot Zeichnungs zu verkaufen. Die Aktien gehandelt werden um 19% auf $ 0,79 auf der Sitzung nach Stunden.
Stopped prediction by melinda for Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.66
02.12.18
02.12.18
€21.00
21.01.19
21.01.19
-32.76%
21.01.19
21.01.19
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€44.46
06.05.16
06.05.16
€57.00
31.08.16
31.08.16
6.41%
31.08.16
31.08.16